Objectives: 1) to evaluate the effectiveness of the e-CBT-i “i-Sleep” compared to a waiting list condition on sleep efficiency at 3, 6 and 12 months in ACC. 2) to assess the effects of eCBT-I on secondary outcomes: fatigue, quality of life, chronic…
Bron
Verkorte titel
Aandoening
- Leukemieën
Aandoening
childhood cancer insomnia
Betreft onderzoek met
Ondersteuning
Onderzoeksproduct en/of interventie
- Psychosociale interventie
Uitkomstmaten
Primaire uitkomstmaten
The primary outcomes include sleep efficiency (actigraphic) and insomnia severity (self-report) and will be evaluated at baseline (T0), 3 (T3), 6 (T6) and 12 (T12) months after randomization. Sleep efficiency will be measured with a 7-day watch Actigraph (GTX3+) and sleep log. SE contains information on difficulties falling asleep as well as difficulties staying asleep. Insomnia severity is measured with the Insomnia Severity Index (ISI)-questionnaire.
Achtergrond van het onderzoek
Insomnia after childhood cancer is prevalent (26-28%) and a disabling sleep disorder impacting quality of life, fatigue, pain and general functioning. Adolescents after childhood cancer (ACC) may be also at increased risk for insomnia, being critically ill during a phase of life that is important in the development of good sleep habits. Currently, screening for insomnia is not routinely done and guidelines for treatment are lacking within pediatric oncology. The first-line treatment of insomnia is the cognitive behavioral therapy for Insomnia (CBT-I)- protocol. However, access this care is often limited. Therefore, the online CBT-I treatment “i-Sleep” has been developed to facilitate access via online care. i-Sleep has been shown feasible and effective in adult (cancer) patients, but it is unknown if online CBT-I is feasible and effective in adolescents after cancer treatment. Therefore, we will evaluate the effectivity of the online CBT-i: i-Sleep youth for adolescents after cancer within a randomized controlled trial compared to a waiting-list control. Managing Insomnia after Childhood cancer in Adolescents (MICADO-2).
Doel van het onderzoek
Objectives: 1) to evaluate the effectiveness of the e-CBT-i “i-Sleep” compared to a waiting list condition on sleep efficiency at 3, 6 and 12 months in ACC. 2) to assess the effects of eCBT-I on secondary outcomes: fatigue, quality of life, chronic stress and psychosocial functioning. 3) To psychometrically assess the responsiveness of the PROMIS sleep item banks over time. 4) Feasibility and acceptability of i-Sleep in the target population
Onderzoeksopzet
Four time points: at baseline (T0), posttreatment after 3 months (T3), follow-up after 6 months (T6) and after 12 months (T12).
Onderzoeksproduct en/of interventie
Online cognitive behavioral therapy (iSleep youth)
Publiek
Shosha Peersmann
Utrecht
The Netherlands
+31650006730
s.h.m.peersmann@prinsesmaximacentrum.nl
Wetenschappelijk
Shosha Peersmann
Utrecht
The Netherlands
+31650006730
s.h.m.peersmann@prinsesmaximacentrum.nl
Leeftijd
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
- diagnosed with insomnia according to the DSM-5 criteria (ISI>8)
- diagnosed with cancer before the age of 19 years
- diagnosed with cancer within the last 7 years
- 12 years or older at the time of the study
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
- anti-cancer treatment within the last 6 months
- patients receiving palliative therapy
- patients that are not able to properly fill out the study questionnaires or participate in the online CBT-I because they are insufficiently fluent in Dutch or have significant cognitive impairment
- patients with comorbidities that can affect sleep: retinoblastoma with severely diminished eye-sight, schizophrenia, substance abuse or history of seizure disorder or seizure in the past 12 months
- pregnancy or parent of a newborn <6 months
- shift work employment
- current psychological treatment for a sleeping disorder or psychopathology
- suicidality
- lack of informed consent
Opzet
Deelname
Voornemen beschikbaar stellen Individuele Patiënten Data (IPD)
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL7220 |
NTR-old | NTR7419 |
CCMO | NL65009.041.18 |